Home LiteratureArticle Details
PMID: 1103722 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article

[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Antimicrobial agents and chemotherapy ·Vol. 8 ·No. 4 ·1975-10-00 ·Pages 396-401

Lode H, Kemmerich B, Koeppe P

Abstract

Using a randomized crossover design involving 12 normal subjects, we studied comparatively the pharmacokinetics and tolerance of three aminoglycoside antibiotics, gentamicin, sisomicin, and tobramycin. Serum concentrations were determined during 8 h and the urine recovery rate was determined within 24 h after a 1-h intravenous infusion of the respective antibiotic in a dose of 1 mg/kg of body weight. Microbiological assay was performed with the agar diffusion test (Bacillus subtilis); pharmacokinetic calculations were performed by means of a digital computer on the basis of a mathematical model of an open, two-compartment system. Of the three antibiotics studied, gentamicin showed the lowest concentration in serum after termination of the 1-h infusion (3.85 +/- 0.67 mug/ml), and the serum-regression curve steadily lay below those of the two other antibiotics. Sisomicin had the highest serum concentrations (4,66 +/- 1.24 mug/ml) and the serum-level curve exceeded that of the two other antibiotics. Tobramycin occupied a position between sisomicin and gentamicin in form of its serum level characteristics. Corresponding to the serum kinetics we also found slight differences in the pharmacokinetic parameters, especially in serum half-lives, elimination constants, and areas under the serum level curves. The test of liver and kidney functions and the hematological systems, as well as the function of the stato-acusticus nerve, showed no pathological changes by any of the three antibiotics tested.

MeSH Terms
Adult Anti-Bacterial Agents/metabolism Clinical Trials as Topic Female Gentamicins/administration & dosage,metabolism Half-Life Humans Infusions, Parenteral Kinetics Male Middle Aged Sisomicin/administration & dosage,metabolism Tobramycin/administration & dosage,metabolism
Chemicals
Anti-Bacterial Agents Gentamicins Tobramycin Sisomicin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lode H
Kemmerich B
Koeppe P
References (21)
21 references, click to expand
  1. GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.
    JAMA. 1964 Sep 14;189:817-22 PMID: 14172278
  2. Pharmacology of gentamicin in man.
    J Infect Dis. 1971 Dec;124 Suppl:S98-105 PMID: 5126254
  3. Serum levels of gentamicin and tobramycin after slow intravenous bolus injection.
    Lancet. 1974 Mar 9;1(7854):378-9 PMID: 4131032
  4. Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans.
    Antimicrob Agents Chemother. 1973 Apr;3(4):469-73 PMID: 4208290
  5. Pharmacokinetic studies of tobramycin and gentamicin.
    Antimicrob Agents Chemother. 1973 Apr;3(4):445-50 PMID: 4208289
  6. The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.
    J Infect Dis. 1974 Aug;130(2):150-4 PMID: 4842335
  7. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Antimicrob Agents Chemother. 1973 Jan;3(1):87-94 PMID: 4790579
  8. Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.
    Antimicrob Agents Chemother. 1973 Jan;3(1):24-8 PMID: 4790572
  9. Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.
    Antimicrob Agents Chemother. 1973 Jan;3(1):125-9 PMID: 4790568
  10. Serum protein binding of the aminoglycoside antibiotics.
    Antimicrob Agents Chemother. 1972 Sep;2(3):214-6 PMID: 4790560
  11. In vitro studies of tobramycin.
    Antimicrob Agents Chemother. 1972 Sep;2(3):109-13 PMID: 4790551
  12. Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.
    Antimicrob Agents Chemother. 1973 Dec;4(6):617-25 PMID: 4793881
  13. Comparative pharmacokinetics of tobramycin and gentamicin.
    Clin Pharmacol Ther. 1973 May-Jun;14(3):396-403 PMID: 4698568
  14. Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.
    Antimicrob Agents Chemother. 1972 Dec;2(6):431-7 PMID: 4670437
  15. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Antimicrob Agents Chemother. 1972 Jan;1(1):41-5 PMID: 4670427
  16. [The use of a digital computer in the development of dosage recommendations for antibiotic therapy].
    Arzneimittelforschung. 1972 Feb;22(2):311-9 PMID: 5067482
  17. Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.
    J Antibiot (Tokyo). 1970 Nov;23(11):559-65 PMID: 4992170
  18. [Pharmacological and therapeutic properties of gentamicin. Experimental studies on the effect level, excretion, stability and therapeutic indications].
    Arzneimittelforschung. 1968 Sep;18(9):1119-23 PMID: 4974678
  19. Antibiotic 6640. II. Fermentation, isolation, and properties.
    J Antibiot (Tokyo). 1970 Nov;23(11):555-8 PMID: 5487130
  20. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.
    J Antibiot (Tokyo). 1970 Nov;23(11):551-4 PMID: 5487129
  21. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.
    J Pharm Sci. 1970 Jan;59(1):53-5 PMID: 5411325
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1975-10-00
Pages
396-401
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC429354
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]